These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10648471)

  • 1. Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis.
    Jones EA; Dekker LR
    Gastroenterology; 2000 Feb; 118(2):431-2. PubMed ID: 10648471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions.
    Jones EA; Neuberger J; Bergasa NV
    QJM; 2002 Aug; 95(8):547-52. PubMed ID: 12145394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy.
    Neuberger J; Jones EA
    Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1393-4. PubMed ID: 11692070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study.
    Terg R; Coronel E; Sordá J; Muñoz AE; Findor J
    J Hepatol; 2002 Dec; 37(6):717-22. PubMed ID: 12445410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study.
    Wolfhagen FH; Sternieri E; Hop WC; Vitale G; Bertolotti M; Van Buuren HR
    Gastroenterology; 1997 Oct; 113(4):1264-9. PubMed ID: 9322521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study.
    Bergasa NV; Alling DW; Talbot TL; Wells MC; Jones EA
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):431-4. PubMed ID: 10459118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral naltrexone on pruritus in cholestatic patients.
    Mansour-Ghanaei F; Taheri A; Froutan H; Ghofrani H; Nasiri-Toosi M; Bagherzadeh AH; Farahvash MJ; Mirmomen S; Ebrahimi-Dariani N; Farhangi E; Pourrasouli Z
    World J Gastroenterol; 2006 Feb; 12(7):1125-8. PubMed ID: 16534857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone: a case report of pruritus from an antipruritic.
    Sullivan JR; Watson A
    Australas J Dermatol; 1997 Nov; 38(4):196-8. PubMed ID: 9431714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis.
    Bergasa NV; Schmitt JM; Talbot TL; Alling DW; Swain MG; Turner ML; Jenkins JB; Jones EA
    Hepatology; 1998 Mar; 27(3):679-84. PubMed ID: 9500694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial.
    Bergasa NV; Alling DW; Talbot TL; Swain MG; Yurdaydin C; Turner ML; Schmitt JM; Walker EC; Jones EA
    Ann Intern Med; 1995 Aug; 123(3):161-7. PubMed ID: 7598296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid antagonists in the treatment of pruritus from cholestatic liver disease.
    Terra SG; Tsunoda SM
    Ann Pharmacother; 1998 Nov; 32(11):1228-30. PubMed ID: 9825091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.
    Setnik B; Roland CL; Goli V; Sommerville K; Webster L
    J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone for cholestatic itch: a systematic review.
    Murray-Brown FL
    BMJ Support Palliat Care; 2021 Jun; 11(2):217-225. PubMed ID: 33692114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases.
    Metze D; Reimann S; Beissert S; Luger T
    J Am Acad Dermatol; 1999 Oct; 41(4):533-9. PubMed ID: 10495371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trials of opiate antagonists for the pruritus of cholestasis: primary efficacy endpoints and opioid withdrawal-like reactions.
    Jones EA
    J Hepatol; 2002 Dec; 37(6):863-5. PubMed ID: 12445430
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute opioid withdrawal on accidental injection of naltrexone.
    Yeo M; Campbell V; Bonomo Y; Sawyer SM
    J Paediatr Child Health; 2003; 39(4):315-7. PubMed ID: 12755943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients].
    Brune A; Metze D; Luger TA; Ständer S
    Hautarzt; 2004 Dec; 55(12):1130-6. PubMed ID: 15517116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonist treatment of opioid withdrawal translational low dose approach.
    Mannelli P; Gottheil E; Van Bockstaele EJ
    J Addict Dis; 2006; 25(2):1-8. PubMed ID: 16785213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study.
    Malekzad F; Arbabi M; Mohtasham N; Toosi P; Jaberian M; Mohajer M; Mohammadi MR; Roodsari MR; Nasiri S
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):948-50. PubMed ID: 19453814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain as a complication of use of opiate antagonists for symptom control in cholestasis.
    McRae CA; Prince MI; Hudson M; Day CP; James OF; Jones DE
    Gastroenterology; 2003 Aug; 125(2):591-6. PubMed ID: 12891561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.